Evidence map›Paper›PMID 40738674›Full record

ArticleInternal medicine (Tokyo, Japan)2026

CO

Hideki Makino, Saki Sahara, Kazuki Oshita, Yuki Kayada, Takahiro Yagi, Issei Katayama, Takuyuki Koda, Hiroto Yoneda, Kotaro Kajiwara

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Hideki MakinoDepartment of Respiratory Medicine, Matsuyama Red Cross Hospital, Japan.
Saki SaharaDepartment of Respiratory Medicine, Matsuyama Red Cross Hospital, Japan.
Kazuki OshitaDepartment of Respiratory Medicine, Matsuyama Red Cross Hospital, Japan.
Yuki KayadaDepartment of Respiratory Medicine, Matsuyama Red Cross Hospital, Japan.
Takahiro YagiDepartment of Respiratory Medicine, Matsuyama Red Cross Hospital, Japan.
Issei KatayamaDepartment of Respiratory Medicine, Matsuyama Red Cross Hospital, Japan.
Takuyuki KodaDepartment of Respiratory Medicine, Matsuyama Red Cross Hospital, Japan.
Hiroto YonedaDepartment of Respiratory Medicine, Matsuyama Red Cross Hospital, Japan.
Kotaro KajiwaraDepartment of Respiratory Medicine, Matsuyama Red Cross Hospital, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aspergillus tracheobronchitis (ATB) is a rare but severe infection in immunocompromised patients that is distinct from invasive pulmonary aspergillosis. A 50-year-old man undergoing dexamethasone, methotrexate, ifosfamide, L-asparaginase, and etoposide chemotherapy for NK/T-cell lymphoma developed febrile neutropenia and worsening respiratory failure. Computed tomography revealed airway epithelial detachment and bronchoscopy confirmed pseudomembrane formation. Due to his "Do Not Intubate" status, mechanical ventilation was not initiated, and he died of CO

Indexed as

Antineoplastic Combined Chemotherapy ProtocolsAspergillosisBronchitisLymphomaTracheitisAspergillusFatal OutcomeHumansImmunocompromised HostMaleMiddle AgedAspergillus tracheobronchitisbronchoscopyCO2 narcosislymphoma

Identifiers

PMID40738674
PMCPMC13070574

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.